### NN 90/2016 (7.10.2016.), Odluka o izmjenama i dopunama Odluke o utvrđivanju Osnovne liste lijekova Hrvatskog zavoda za zdravstveno osiguranje

HRVATSKI ZAVOD ZA ZDRAVSTVENO OSIGURANJE

1916

Na osnovi članka 20. stavka 7. Zakona o obveznom zdravstvenom osiguranju (»Narodne novine« broj 80/13. i 137/13.) i članka 26. točke 10. Statuta Hrvatskog zavoda za zdravstveno osiguranje (»Narodne novine« broj 18/09., 33/10., 08/11., 18/13., 1/14. i 83/15.) Upravno vijeće Hrvatskog zavoda za zdravstveno osiguranje na 7. sjednici održanoj 6. listopada 2016. godine donijelo je

ODLUKU

O IZMJENAMA I DOPUNAMA ODLUKE O UTVRĐIVANJU OSNOVNE LISTE LIJEKOVA HRVATSKOG ZAVODA ZA ZDRAVSTVENO OSIGURANJE

Članak 1.

U Odluci o utvrđivanju Osnovne liste lijekova Hrvatskog zavoda za zdravstveno osiguranje (»Narodne novine« broj 63/16., 68/16. – ispravak) u Osnovnoj listi lijekova pod šiframa anatomsko-terapijsko-kemijske (ATK) klasifikacije lijekova Svjetske zdravstvene organizacije mijenjaju se sljedeći podaci:

»

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Šifra ATK | Oznaka | Nezaštićeno ime lijeka | DDD i jed. mj. | Cijena za DDD | Cijena za DDD (s PDV-om) | Način primjene | Nositelj odobrenja | Proizvođač | Zaštićeno ime lijeka | Oblik, jačina i pakiranje lijeka | Cijena jed. oblika | Cijena jed. oblika (s PDV-om) | Cijena orig. pakiranja | Cijena orig. pakiranja (s PDV-om) | R/RS |
| 1. | 2. | 3. | 4. | 5. | 6. | 7. | 8. | 9. | 10. | 11. | 12. | 13. | 14. | 15. | 16. |
| D07XC01 411 |  | betametazon + salicilna kiselina |  |  |  | L | Belupo d.d. | Belupo | Belosalic | mast 1x30 g (0,5 mg/g+30 mg/g) | 28,96 | 30,41 | 28,96 | 30,41 | R |
| D07XC01 461 |  | betametazon + salicilna kiselina |  |  |  | L | Merck Sharp & Dohme d.o.o. | Schering- Plough | Diprosalic | mast 1x15 g (0,5 mg/g+30 mg/g) | 14,48 | 15,20 | 14,48 | 15,20 | R |
| D07XC01 462 |  | betametazon + salicilna kiselina |  |  |  | L | Merck Sharp & Dohme d.o.o. | Schering- Plough | Diprosalic | mast 1x30 g (0,5 mg/g+30 mg/g) | 28,96 | 30,41 | 28,96 | 30,41 | R |
| D07XC01 712 |  | betametazon + salicilna kiselina |  |  |  | L | Belupo d.d. | Belupo | Belosalic | losion 1x100 ml (0,5 mg/g+20 mg/g) | 87,75 | 92,14 | 87,75 | 92,14 | R |
| H02AB04 064 | PO | metilprednizolon-sukcinat-natrij | 20 mg | 5,50 | 5,77 | P | Pfizer Croatia d.o.o. | Pfizer | Solu Medrol | amp. 1x40 mg/ml | 10,99 | 11,54 | 10,99 | 11,54 |  |
| H02AB04 066 | PR | metilprednizolon-sukcinat-natrij | 20 mg | 3,51 | 3,69 | P | Pfizer Croatia d.o.o. | Pfizer | Solu Medrol | amp. 1x125 mg/2 ml | 21,95 | 23,05 | 21,95 | 23,05 |  |
| J01DC02 043 | DS | cefuroksimNJ102 | 3 g | 32,16 | 33,77 | P | Alkaloid d.o.o. | Alkaloid | Furexa | praš. za otop. za inj. ili inf., boč. stakl. 5x1,5 g | 16,08 | 16,88 | 80,40 | 84,42 |  |
| J01FA10 304 |  | azitromicin | 0,3 g | 11,34 | 11,91 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Sumamed | praš. za oral. susp., 1x20 ml (100 mg/5 ml) | 15,12 | 15,88 | 15,12 | 15,88 | RRJ12 |
| J01FA10 306 |  | azitromicin | 0,3 g | 11,34 | 11,91 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Sumamed 1.200 | praš. za oral. susp., 1x30 ml (200 mg/5 ml) | 45,36 | 47,63 | 45,36 | 47,63 | RRJ12 |
| J01FA10 308 |  | azitromicin | 0,3 g | 11,34 | 11,91 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Sumamed forte | praš. za oral. susp., 1x15 ml (200 mg/5 ml) | 22,68 | 23,81 | 22,68 | 23,81 | RRJ12 |
| J01FA10 309 |  | azitromicin | 0,3 g | 11,34 | 11,91 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Sumamed 1.500 | praš. za oral. susp., 1x37,5 ml (200 mg/5 ml) | 56,70 | 59,54 | 56,70 | 59,54 | RRJ12 |
| J01FF01 065 | DS | klindamicin | 1,8 g | 34,81 | 36,55 | P | MIP Pharma Croatia d.o.o. | Chephasaar Chem.-pharm. Fabrik GmbH | Clindamycin MIP/Klindamicin-MIP | otop. za inj., amp. 5x900 mg/6 ml | 17,41 | 18,28 | 87,03 | 91,38 |  |
| J01FF01 071 | DS | klindamicin | 1,8 g | 40,96 | 43,01 | P | MIP Pharma Croatia d.o.o. | Chephasaar Chem.-pharm. Fabrik GmbH | Clindamycin MIP/Klindamicin-MIP | otop. za inj., amp. 5x600 mg/4 ml | 13,65 | 14,33 | 68,27 | 71,68 |  |
| J01MA02 122 |  | ciprofloksacin | 1 g | 9,23 | 9,70 | O | Sandoz d.o.o. | Sandoz-Salutas | Ciprofloksacin Sandoz | tbl. film obl. 10x500 mg | 4,62 | 4,85 | 46,17 | 48,48 | RSRJ13 |
| J01MA14 131 |  | moksifloksacin | 0,4 g | 5,26 | 5,52 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH, KRKA-FARMA d.o.o. | Moloxin | tbl. film obl. 5x400 mg | 5,26 | 5,52 | 26,30 | 27,62 | RSRJ16 |
| J01MA14 132 |  | moksifloksacin | 0,4 g | 5,26 | 5,52 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH, KRKA-FARMA d.o.o. | Moloxin | tbl. film obl. 7x400 mg | 5,26 | 5,52 | 36,82 | 38,66 | RSRJ16 |
| L02BB03 121 |  | bikalutamid | 50 mg | 6,07 | 6,37 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Bikalutamid JGL | tbl. film obl. 28x50 mg | 6,07 | 6,37 | 169,91 | 178,41 | RSRL23 |
| L02BB03 122 |  | bikalutamid | 50 mg | 7,68 | 8,07 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Bikalutamid JGL | tbl. film obl. 28x150 mg | 23,05 | 24,20 | 645,39 | 677,66 | RSRL23 |
| L02BG03 121 |  | anastrozol | 1 mg | 5,25 | 5,51 | O | Sandoz d.o.o. | Sandoz-Salutas | Anastrozol Sandoz | tbl. film obl. 28x1 mg | 5,25 | 5,51 | 147,00 | 154,35 | RSRL24 |
| L02BG03 122 |  | anastrozol | 1 mg | 5,25 | 5,51 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Anastrozol JGL | tbl. film obl. 28x1 mg | 5,25 | 5,51 | 147,00 | 154,35 | RSRL24 |
| N02AX06 161 |  | tapentadol | 0,4 g | 36,91 | 38,75 | O | Grünenthal GmbH | Grünenthal GmbH | Palexia retard | tbl. s prod. oslob. 30x50 mg | 4,61 | 4,84 | 138,40 | 145,32 | RSRN02 |
| N02AX06 162 |  | tapentadol | 0,4 g | 36,16 | 37,97 | O | Grünenthal GmbH | Grünenthal GmbH | Palexia retard | tbl. s prod. oslob. 30x100 mg | 9,04 | 9,49 | 271,20 | 284,76 | RSRN02 |
| N02AX06 163 |  | tapentadol | 0,4 g | 34,37 | 36,09 | O | Grünenthal GmbH | Grünenthal GmbH | Palexia retard | tbl. s prod. oslob. 30x150 mg | 12,89 | 13,53 | 386,70 | 406,04 | RSRN02 |
| N03AX16 133 |  | pregabalin | 0,3 g | 3,22 | 3,38 | O | KRKA-FARMA d.o.o. | KRKA d.d., TAD Pharma GmbH | Pragiola | caps. tvrda 56x150 mg | 1,61 | 1,69 | 90,16 | 94,67 | RSpn21 |
| N03AX16 134 |  | pregabalin | 0,3 g | 3,26 | 3,42 | O | KRKA-FARMA d.o.o. | KRKA d.d., TAD Pharma GmbH | Pragiola | caps. tvrda 56x300 mg | 3,26 | 3,42 | 182,56 | 191,69 | RSpn21 |
| N06AX21 131 |  | duloksetin | 60 mg | 4,50 | 4,73 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH | Dulsevia | caps. žel. otp. tvrda 28x30 mg | 2,25 | 2,36 | 63,00 | 66,15 | RRN18 |
| N06AX21 132 |  | duloksetin | 60 mg | 4,50 | 4,73 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH | Dulsevia | caps. žel. otp. tvrda 28x60 mg | 4,50 | 4,73 | 126,00 | 132,30 | RRN18 |
| R03DX05 061 | DS | omalizumabNR502 | 16 mg | 280,30 | 294,31 | P | Novartis Europharm Limited | Novartis Pharma GmbH | Xolair | otop. za inj., štrc. napunj. 1x150 mg/ml | 2.627,80 | 2.759,19 | 2.627,80 | 2.759,19 |  |
| R06AB03 271 |  | dimetinden | 4 mg | 3,72 | 3,91 | O | CLINRES FARMACIJA d.o.o. | Novartis Consumer Health | Fenistil 0,1% | kapi za oral. primj. 1x20 ml (1mg/ml) | 18,56 | 19,49 | 18,56 | 19,49 | R |
| S01LA05 061 | DS | afliberceptNS101 |  |  |  | P | Bayer Pharma AG | Bayer Pharma AG | Eylea | otop. za inj., boč. stak. 1x40 mg/ml | 5.558,98 | 5.836,93 | 5.558,98 | 5.836,93 |  |
| V08CA09 071 | KL | gadobutrol |  |  |  | P | Bayer d.o.o. | Bayer Pharma AG | Gadovist | otop. za inj. u napunj. štrc./ulošku 5x7,5 ml (604,72 mg/1 mmol/ml) | 368,84 | 387,28 | 1.844,18 | 1.936,39 |  |
| V08CA09 073 | KL | gadobutrol |  |  |  | P | Bayer d.o.o. | Bayer Pharma AG | Gadovist | otop. za inj., boč. 1x15 ml (604,72 mg/1 mmol/ml) | 722,00 | 758,10 | 722,00 | 758,10 |  |
| V20AA01 926 | RZ | sterilna gaza |  |  |  | L | Lola Ribar d.d. | Lola Ribar | Lola care sterilna gaza 1/2 m | 1 x 1/2 m | 2,30 | 2,42 | 2,30 | 2,42 | RRZ01 |
| V20AA01 936 | RZ | sterilna gaza |  |  |  | L | Lola Ribar d.d. | Lola Ribar | Lola care sterilna gaza 1 m | 1 x 1 m | 3,70 | 3,89 | 3,70 | 3,89 | RRZ01 |

«

Dodaju se nove šifre anatomsko-terapijsko-kemijske (ATK) klasifikacije lijekova Svjetske zdravstvene organizacije, sa sljedećim podacima:

»

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Šifra ATK | Oznaka | Nezaštićeno ime lijeka | DDD i jed. mj. | Cijena za DDD | Cijena za DDD (s PDV-om) | Način primjene | Nositelj odobrenja | Proizvođač | Zaštićeno  ime lijeka | Oblik, jačina i pakiranje lijeka | Cijena jed. oblika | Cijena jed. oblika (s PDV-om) | Cijena orig. pakiranja | Cijena orig. pakiranja (s PDV-om) | R/RS |
| 1. | 2. | 3. | 4. | 5. | 6. | 7. | 8. | 9. | 10. | 11. | 12. | 13. | 14. | 15. | 16. |
| A02BC02 181 |  | pantoprazol | 40 mg | 0,94 | 0,99 | O | Farmal d.d. | mibe GmbH | Apazol A | tbl. žel. otp. 28x20 mg | 0,47 | 0,49 | 13,17 | 13,83 | RRA02 |
| A02BC02 182 |  | pantoprazol | 40 mg | 0,89 | 0,93 | O | Farmal d.d. | mibe GmbH | Apazol A | tbl. žel. otp. 56x20 mg | 0,44 | 0,47 | 24,80 | 26,04 | RRA02 |
| A02BC02 183 |  | pantoprazol | 40 mg | 0,91 | 0,96 | O | Farmal d.d. | mibe GmbH | Apazol A | tbl. žel. otp. 28x40 mg | 0,91 | 0,96 | 25,48 | 26,75 | RRA02 |
| A04AA05 001 | DS | palonosetronNA402 | 0,25 mg | 363,64 | 381,82 | P | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Palonozetron Pliva | otop. za inj. boč. 1x250 mcg/5 ml | 363,64 | 381,82 | 363,64 | 381,82 |  |
| A04AA05 041 | DS | palonosetronNA402 | 0,25 mg | 294,55 | 309,28 | P | Accord Healthcare Ltd | Accord Healthcare Ltd | Palonosetron Accord | otop. za inj. boč. stakl. 1x250 mcg/5 ml | 294,55 | 309,28 | 294,55 | 309,28 |  |
| A04AA05 071 | DS | palonosetronNA402 | 0,25 mg | 327,28 | 343,64 | P | Medochemie Ltd. | Medochemie Ltd. | Ferant | otop. za inj., amp. 1x250 mcg/5 ml | 327,28 | 343,64 | 327,28 | 343,64 |  |
| A04AA05 072 | DS | palonosetronNA402 | 0,25 mg | 327,28 | 343,64 | P | Medochemie Ltd. | Medochemie Ltd. | Ferant | otop. za inj., amp. 5x250 mcg/5 ml | 327,28 | 343,64 | 1.636,40 | 1.718,22 |  |
| B01AC16 071 | DS | eptifibatidNB106 |  |  |  | P | Accord Healthcare Ltd | Accord Healthcare Ltd | Eptifibatid Accord | otop. za inj., boč. stakl. 1x10 ml (2 mg/ml) | 95,61 | 100,39 | 95,61 | 100,39 |  |
| B01AC16 072 | DS | eptifibatidNB106 |  |  |  | P | Accord Healthcare Ltd | Accord Healthcare Ltd | Eptifibatid Accord | otop. za inj., boč. stakl. 1x100 ml (0,75 mg/ml) | 301,05 | 316,10 | 301,05 | 316,10 |  |
| B02BD02 090 | DS | rekombinantni čimbenik VIII (oktokog alfa)NB205 | 500 i.j. | 2.569,14 | 2.697,60 | P | Bayer Pharma AG | Bayer HealthCare Manufacturing S.r.l. | Kogenate Bayer 1000 i.j | praš. i otap. za otop. za inj. boč. 1000 i.j.+boč. s otap. 2,5 ml +Bio-Set | 5.138,28 | 5.395,19 | 5.138,28 | 5.395,19 |  |
| H05BX01 171 | DS | sinakalcetNH502 | 60 mg | 56,08 | 58,89 | O | Accord Healthcare Ltd | GE Pharmaceuticals Ltd., S.C. Polisano Pharmaceuticals S.R.L. | Sinakalcet Accord | tbl. film obl. 28x30 mg | 28,04 | 29,44 | 785,18 | 824,44 |  |
| H05BX01 172 | DS | sinakalcetNH502 | 60 mg | 56,08 | 58,89 | O | Accord Healthcare Ltd | GE Pharmaceuticals Ltd., S.C. Polisano Pharmaceuticals S.R.L. | Sinakalcet Accord | tbl. film obl. 28x60 mg | 56,08 | 58,89 | 1.570,35 | 1.648,87 |  |
| J01MA14 031 | DS | moksifloksacinNJ105 | 400 mg | 109,40 | 114,87 | P | KRKA-FARMA d.o.o. | Krka dd, TAD Pharma GmbH | Moloxin | otop. za inf., boca 1x400 mg/250 ml | 109,40 | 114,87 | 109,40 | 114,87 |  |
| J01MA14 173 |  | moksifloksacin | 0,4 g | 4,77 | 5,01 | O | DOUBLE-E-PHARMA Limited | Laboratories BTT | Rivomox | tbl. film obl. 5x400 mg | 4,77 | 5,01 | 23,85 | 25,04 | RSpj05 |
| J01MA14 174 |  | moksifloksacin | 0,4 g | 4,86 | 5,10 | O | DOUBLE-E-PHARMA Limited | Laboratories BTT | Rivomox | tbl. film obl. 7x400 mg | 4,86 | 5,10 | 34,02 | 35,72 | RSpj05 |
| J01XX01 141 |  | fosfomicin | 3 g | 21,02 | 22,07 | O | PharmaS d.o.o. | Labiana Pharmaceuticals S.L.U. | Urifos | gran. za oral. otop., vreć. 1x3 g | 21,02 | 22,07 | 21,02 | 22,07 | R |
| J01XX01 142 |  | fosfomicin | 3 g | 21,04 | 22,09 | O | PharmaS d.o.o. | Labiana Pharmaceuticals S.L.U. | Urifos | gran. za oral. otop., vreć. 2x3 g | 21,04 | 22,09 | 42,07 | 44,17 | R |
| J01XX01 143 |  | fosfomicin | 3 g | 31,11 | 32,67 | O | PharmaS d.o.o. | Labiana Pharmaceuticals S.L.U. | Urifos | gran. za oral. otop., vreć. 1x2 g | 20,74 | 21,78 | 20,74 | 21,78 | R |
| J01XX08 131 | DS | linezolidNJ106 | 1,2 g | 412,58 | 433,21 | O | KRKA-FARMA d.o.o. | Krka dd, TAD Pharma GmbH | Linezolid Krka | tbl. film obl. 10x600 mg | 206,29 | 216,60 | 2.062,89 | 2.166,03 |  |
| J02AX04 021 | DS | kaspofunginNJ201 | 50 mg | 2.249,39 | 2.361,86 | P | Sandoz d.o.o. | Xellia Pharmaceuticals Ltd. | Kaspofungin Sandoz | praš. za konc. za otop. za inf., boč. 1x50 mg | 2.249,39 | 2.361,86 | 2.249,39 | 2.361,86 |  |
| J05AR02 001 | DS | abakavir + lamivudinNJ501 |  |  |  | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o., Teva Pharma B.V., Merckle GmbH | Abakavir/lamivudin Pliva | tbl. film obl. 30x(600 mg+300 mg) | 60,66 | 63,69 | 1.819,66 | 1.910,64 |  |
| J05AR02 121 | DS | abakavir + lamivudinNJ501 |  |  |  | O | Sandoz d.o.o. | Lupin (Europe) Ltd | Abakavir/lamivudin Sandoz | tbl. film obl. 30x(600 mg+300 mg) | 54,59 | 57,32 | 1.637,69 | 1.719,57 |  |
| J05AR03 101 | DS | emtricitabin + tenofovir NJ501 |  |  |  | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o., Teva Operations Poland Sp. z o.o. | Emtricitabin/tenofovirdizoproksil Pliva | tbl. film obl. 30x(200 mg +245 mg) | 80,95 | 85,00 | 2.428,53 | 2.549,96 |  |
| J06BA02 081 | DS | imunoglobulin za intraven. primjenu 7 S NJ601 |  |  |  | P | OCTAPHARMA (IP) Limited | Octapharma | Panzyga | otop. za inf., boč. 1x25 ml (100 mg/ml) | 830,08 | 871,58 | 830,08 | 871,58 |  |
| J06BA02 082 | DS | imunoglobulin za intraven. primjenu 7 S NJ601 |  |  |  | P | OCTAPHARMA (IP) Limited | Octapharma | Panzyga | otop. za inf., boca 1x50 ml (100 mg/ml) | 1.925,09 | 2.021,34 | 1.925,09 | 2.021,34 |  |
| J06BA02 083 | DS | imunoglobulin za intraven. primjenu 7 S NJ601 |  |  |  | P | OCTAPHARMA (IP) Limited | Octapharma | Panzyga | otop. za inf., boca 1x100 ml (100 mg/ml) | 3.225,04 | 3.386,29 | 3.225,04 | 3.386,29 |  |
| J06BA02 084 | DS | imunoglobulin za intraven. primjenu 7 S NJ601 |  |  |  | P | OCTAPHARMA (IP) Limited | Octapharma | Panzyga | otop. za inf., boca 1x200 ml (100 mg/ml) | 6.450,08 | 6.772,58 | 6.450,08 | 6.772,58 |  |
| J06BA02 085 | DS | imunoglobulin za intraven. primjenu 7 S NJ601 |  |  |  | P | OCTAPHARMA (IP) Limited | Octapharma | Panzyga | otop. za inf., boca 1x300 ml (100 mg/ml) | 9.675,12 | 10.158,88 | 9.675,12 | 10.158,88 |  |
| L01BC06 175 |  | kapecitabin |  |  |  | O | Accord Healthcare Ltd | Accord Healthcare Limited | Kapecitabin Accord | tbl. film obl. 120x500 mg | 6,22 | 6,53 | 746,28 | 783,59 | RSRL02 |
| L01CD02 084 | DS | docetaksel |  |  |  | P | Accord Healthcare Ltd | Accord Healthcare Limited | Docetaxel Accord | konc. za otop. za inf., boč. stakl. 1x20 mg/ml | 320,83 | 336,87 | 320,83 | 336,87 |  |
| L01CD02 085 | DS | docetaksel |  |  |  | P | Accord Healthcare Ltd | Accord Healthcare Limited | Docetaxel Accord | konc. za otop. za inf., boč. stakl. 1x80 mg/4 ml | 1.119,02 | 1.174,97 | 1.119,02 | 1.174,97 |  |
| L01CD02 086 | DS | docetaksel |  |  |  | P | Accord Healthcare Ltd | Accord Healthcare Limited | Docetaxel Accord | konc. za otop. za inf., boč. stakl. 1x160 mg/8 ml | 2.015,54 | 2.116,32 | 2.015,54 | 2.116,32 |  |
| L01XE01 193 | DS | imatinibNL115 |  |  |  | O | Accord Healthcare Ltd | Accord Healthcare Limited | Imatinib Accord | tbl. film obl. 60x100 mg | 47,57 | 49,94 | 2.853,90 | 2.996,60 |  |
| L01XE01 194 | DS | imatinibNL115 |  |  |  | O | Accord Healthcare Ltd | Accord Healthcare Limited | Imatinib Accord | tbl. film obl. 30x400 mg | 188,73 | 198,17 | 5.661,90 | 5.945,00 |  |
| L01XE14 161 | DS | bosutinibNL119 |  |  |  | O | Pfizer Ltd. | Pfizer Manufacturing Deutschland GmbH | Bosulif | tbl. film obl. 28x100 mg | 176,23 | 185,04 | 4.934,40 | 5.181,12 |  |
| L01XE14 162 | DS | bosutinibNL119 |  |  |  | O | Pfizer Ltd. | Pfizer Manufacturing Deutschland GmbH | Bosulif | tbl. film obl. 28x500 mg | 882,75 | 926,89 | 24.717,00 | 25.952,85 |  |
| L01XX19 067 | DS | irinotekanNL125 |  |  |  | P | Accord Healthcare Ltd | Accord Healthcare Limited | Irinotekan Accord | konc. za otop. za inf, boč. 1x100 mg/5 ml | 393,66 | 413,34 | 393,66 | 413,34 |  |
| L01XX19 068 | DS | irinotekanNL125 |  |  |  | P | Accord Healthcare Ltd | Accord Healthcare Limited | Irinotekan Accord | konc. za otop. za inf, boč. 1x300 mg/15 ml | 1.180,98 | 1.240,03 | 1.180,98 | 1.240,03 |  |
| L01XX19 069 | DS | irinotekanNL125 |  |  |  | P | Accord Healthcare Ltd | Accord Healthcare Limited | Irinotekan Accord | konc. za otop. za inf, boč. 1x500 mg/25 ml | 1.968,30 | 2.066,72 | 1.968,30 | 2.066,72 |  |
| L02BA03 001 | DS | fulvestrantNL202 | 8,3 mg | 50,44 | 52,96 | P | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Fulvestrant Pliva | otop. za inj., štrc. napunj. 2x250 mg/5 ml | 1.519,36 | 1.595,33 | 3.038,72 | 3.190,66 |  |
| L03AA02 085 | DS | filgrastim | 0,35 mg | 305,80 | 321,09 | P | Accord Healthcare Ltd | Accord Healthcare Limited | Accofil | otop. za inj. ili inf., štrc. stakl. napunj. 5x30 MU/0,5 ml (0,6 mg/ml) | 262,12 | 275,22 | 1.310,58 | 1.376,11 |  |
| L03AA02 086 | DS | filgrastim | 0,35 mg | 305,80 | 321,09 | P | Accord Healthcare Ltd | Accord Healthcare Limited | Accofil | otop. za inj. ili inf., štrc. stakl. napunj. 5x48 MU/0,5 ml (0,96 mg/ml) | 419,39 | 440,36 | 2.096,93 | 2.201,78 |  |
| L03AX13 071 | DS | glatirameracetatNL303 | 20 mg | 131,53 | 138,11 | P | Alvogen IPCo S.ar.l. | Synthon Hispania S.L., Synthon BV | Remurel | otop. za inj., štrc. napunj. 28x20 mg/ml | 131,53 | 138,11 | 3.682,97 | 3.867,12 |  |
| L04AD01 101 |  | ciklosporinNL415 | 0,25 g | 40,68 | 42,71 | O | PLIVA HRVATSKA d.o.o. | Teva Czech Industries s.r.o. | Ciqorin | caps. meka 50x10 mg | 1,63 | 1,71 | 81,36 | 85,43 | RSRL45 |
| L04AD01 102 |  | ciklosporinNL415 | 0,25 g | 32,55 | 34,17 | O | PLIVA HRVATSKA d.o.o. | Teva Czech Industries s.r.o. | Ciqorin | caps. meka 50x25 mg | 3,25 | 3,42 | 162,73 | 170,87 | RSRL45 |
| L04AD01 103 |  | ciklosporinNL415 | 0,25 g | 29,19 | 30,65 | O | PLIVA HRVATSKA d.o.o. | Teva Czech Industries s.r.o. | Ciqorin | caps. meka 50x50 mg | 5,84 | 6,13 | 291,91 | 306,51 | RSRL45 |
| L04AD01 104 |  | ciklosporinNL415 | 0,25 g | 30,37 | 31,89 | O | PLIVA HRVATSKA d.o.o. | Teva Czech Industries s.r.o. | Ciqorin | caps. meka 50x100 mg | 12,15 | 12,76 | 607,47 | 637,84 | RSRL45 |
| M05BA08 082 | DS | zoledronatna kiselinaNM501 | 4 mg | 717,16 | 753,02 | P | Accord Healthcare Ltd | Accord Healthcare Limited | Zoledronatna kiselina Accord | konc. za otop. za inf., boč. 1x4 mg/5 ml | 717,16 | 753,02 | 717,16 | 753,02 |  |
| N02AE01 901 |  | buprenorfin | 1,2 mg | 1,66 | 1,74 | TD | PLIVA HRVATSKA d.o.o. | Tesa Labtec GmbH | Laribon | flaster transd. 4x20 mg (35 mcg/h) | 27,64 | 29,02 | 110,57 | 116,10 | RRN02 |
| N02AE01 902 |  | buprenorfin | 1,2 mg | 1,61 | 1,69 | TD | PLIVA HRVATSKA d.o.o. | Tesa Labtec GmbH | Laribon | flaster transd. 4x30 mg (52,50 mcg/h) | 40,24 | 42,25 | 160,97 | 169,02 | RRN02 |
| N02AE01 903 |  | buprenorfin | 1,2 mg | 1,52 | 1,60 | TD | PLIVA HRVATSKA d.o.o. | Tesa Labtec GmbH | Laribon | flaster transd. 4x40 mg (70 mcg/h) | 50,69 | 53,23 | 202,77 | 212,91 | RRN02 |
| N03AX14 184 |  | levetiracetam | 1,5 g | 3,75 | 3,94 | O | Accord Healthcare Ltd | Accord Healthcare Limited | Levetiracetam Accord | tbl. film obl. 60x250 mg | 0,63 | 0,66 | 37,50 | 39,38 | RSRN15 |
| N03AX14 185 |  | levetiracetam | 1,5 g | 3,71 | 3,89 | O | Accord Healthcare Ltd | Accord Healthcare Limited | Levetiracetam Accord | tbl. film obl. 60x500 mg | 1,24 | 1,30 | 74,11 | 77,82 | RSRN15 |
| N03AX15 161 |  | zonisamid | 0,2 g | 12,23 | 12,84 | O | Makpharm d.o.o. | Chanelle Medical | Zonisamid Makpharm | caps. tvrda 28x25 mg | 1,53 | 1,60 | 42,79 | 44,93 | RSRN19 |
| N03AX15 162 |  | zonisamid | 0,2 g | 12,23 | 12,84 | O | Makpharm d.o.o. | Chanelle Medical | Zonisamid Makpharm | caps. tvrda 28x50 mg | 3,06 | 3,21 | 85,61 | 89,89 | RSRN19 |
| N03AX15 163 |  | zonisamid | 0,2 g | 12,23 | 12,84 | O | Makpharm d.o.o. | Chanelle Medical | Zonisamid Makpharm | caps. tvrda 98x100 mg | 6,11 | 6,42 | 599,09 | 629,04 | RSRN19 |
| N03AX16 132 |  | pregabalin | 0,3 g | 4,14 | 4,35 | O | KRKA-FARMA d.o.o. | KRKA d.d., TAD Pharma GmbH | Pragiola | caps. tvrda 56x75 mg | 1,04 | 1,09 | 58,02 | 60,92 | RSpn21 |
| N03AX16 186 |  | pregabalin | 0,3 g | 3,82 | 4,01 | O | Accord Healthcare Ltd | Accord Healthcare Limited | Pregabalin Accord | caps. tvrda 56x75 mg | 0,96 | 1,00 | 53,48 | 56,15 | RSpn21 |
| N03AX16 187 |  | pregabalin | 0,3 g | 2,93 | 3,08 | O | Accord Healthcare Ltd | Accord Healthcare Limited | Pregabalin Accord | caps. tvrda 56x150 mg | 1,47 | 1,54 | 82,10 | 86,21 | RSpn21 |
| N04BD02 192 |  | razagilin | 1 mg | 7,01 | 7,36 | O | STADA d.o.o. | STADA Arzneimittel GmbH | Razagilin Stada | tbl. 28x1 mg | 7,01 | 7,36 | 196,32 | 206,14 | Rpn06 |
| N05AX12 181 |  | aripiprazol | 15 mg | 4,74 | 4,98 | O | Accord Healthcare Ltd | Accord Healthcare Ltd | Aripiprazole Accord | tbl. 28x10 mg | 3,16 | 3,32 | 88,45 | 92,87 | RSRN06 |
| N05AX12 182 |  | aripiprazol | 15 mg | 4,50 | 4,73 | O | Accord Healthcare Ltd | Accord Healthcare Ltd | Aripiprazole Accord | tbl. 28x15 mg | 4,50 | 4,73 | 126,10 | 132,41 | RSRN06 |
| N05AX12 183 |  | aripiprazol | 15 mg | 4,62 | 4,85 | O | Accord Healthcare Ltd | Accord Healthcare Ltd | Aripiprazole Accord | tbl. 28x30 mg | 9,23 | 9,70 | 258,55 | 271,48 | RSRN06 |
| N06AX21 183 |  | duloksetin | 60 mg | 3,33 | 3,50 | O | Medochemie Ltd. | Medochemie Ltd. | Onelar | caps. žel. otp. tvrda 28x30 mg | 1,67 | 1,75 | 46,62 | 48,95 | RRN18 |
| N06AX21 184 |  | duloksetin | 60 mg | 3,33 | 3,50 | O | Medochemie Ltd. | Medochemie Ltd. | Onelar | caps. žel. otp. tvrda 28x60 mg | 3,33 | 3,50 | 93,23 | 97,89 | RRN18 |
| R03AK07 376 |  | budesonid + formoterol |  |  |  | I | AstraZeneca d.o.o. | AstraZeneca | Symbicort | inhal. stlač., susp., 120x(160+4,5 mcg) | 2,27 | 2,38 | 272,40 | 286,02 | RRR10 |
| S01EC03 781 |  | dorzolamid | 0,3 ml | 2,01 | 2,11 | L | Alvogen IPCo S.ar.l. | Rafarm S.A. | Dorvis | kapi za oči 1x5 ml (20 mg/ml) | 33,50 | 35,18 | 33,50 | 35,18 | RSRS01 |
| S01ED51 771 |  | timolol + dorzolamid |  |  |  | L | Alvogen IPCo S.ar.l. | Rafarm S.A. | Dorvis plus | kapi za oči, 1x5 ml (5 mg+20 mg/ml) | 36,20 | 38,01 | 36,20 | 38,01 | RSRS01 |
| V06CA01 392 |  | dijetetski preparatNV601 |  |  |  | O | G-M Pharma Zagreb d.o.o. | SHS International Ltd. | PKU Lophlex | prah, vreć. 30x27,8 g | 82,85 | 86,99 | 2.485,35 | 2.609,62 | RSfRV17 |
| V06DX01 380 |  | dijetetski preparatmv605 |  |  |  | O | G-M Pharma Zagreb d.o.o. | SHS International Ltd. | Neocate Junior | limenka 1x400 g | 269,44 | 282,91 | 269,44 | 282,91 | RSpv01 |
| V06DX01 381 |  | dijetetski preparatmv603 |  |  |  | O | G-M Pharma Zagreb d.o.o. | SHS International Ltd. | Neocate LCP | limenka 1x400 g | 260,91 | 273,96 | 260,91 | 273,96 | RSpv01 |

Legenda smjernica:

RN19: Samo za bolesnike s epilepsijom refrakternom na druge antiepileptike (N03AA, N03AB, N03AD, N03AE, N03AF i N03AG), kao dodatna terapija u liječenju parcijalnih napadaja sa sekundarnom generalizacijom ili bez nje kod bolesnika s epilepsijom starijih od 6 godina, po preporuci specijalista neurologa ili pedijatra.

RR10: Za liječenje odraslih bolesnika s kroničnom opstruktivnom plućnom bolesti (KOPB), koji imaju forsirani ekspiracijski volumen u prvoj sekundi FEV1<60% od predviđene normale (nakon primjene bronhodilatatora) i anamnezom egzacerbacija bolesti unatoč redovitoj terapiji bronhodilatatorima.«

Brišu se šifre anatomsko-terapijsko-kemijske (ATK) klasifikacije lijekova Svjetske zdravstvene organizacije, sa sljedećim podacima:

»

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Šifra ATK | Oznaka | Nezaštićeno ime lijeka | DDD i jed. mj. | Cijena za DDD | Cijena za DDD (s PDV-om) | Način primjene | Nositelj odobrenja | Proizvođač | Zaštićeno ime lijeka | Oblik, jačina i pakiranje lijeka | Cijena jed. oblika | Cijena jed. oblika (s PDV-om) | Cijena orig. pakiranja | Cijena orig. pakiranja (s PDV-om) | R/RS |
| 1. | 2. | 3. | 4. | 5. | 6. | 7. | 8. | 9. | 10. | 11. | 12. | 13. | 14. | 15. | 16. |
| B01AB04 075 | DSPO | dalteparinNB102 | 2.5 T i.j. | 7,76 | 8,15 | P | Pfizer Croatia d.o.o. | Pfizer | Fragmin | štrc. stakl. 5x10.000 i.j./0,4 ml | 31.03 | 32,58 | 155.15 | 162,91 |  |
| B01AB04 076 | DSPO | dalteparinNB102 | 2.5 T i.j. | 8,04 | 8,44 | P | Pfizer Croatia d.o.o. | Pfizer | Fragmin | štrc. stakl. 5x12.500 i.j./0,5 ml | 40.20 | 42,21 | 200.98 | 211,03 |  |
| B01AB04 077 | DSPO | dalteparinNB102 | 2.5 T i.j. | 8,02 | 8,42 | P | Pfizer Croatia d.o.o. | Pfizer | Fragmin | štrc. stakl. 5x15.000 i.j./0,6 ml | 48.12 | 50,53 | 240.60 | 252,63 |  |
| B01AB04 078 | DSPO | dalteparinNB102 | 2.5 T i.j. | 7,25 | 7,61 | P | Pfizer Croatia d.o.o. | Pfizer | Fragmin | štrc. stakl. 5x18.000 i.j./0,72 ml | 52.21 | 54,82 | 261.04 | 274,09 |  |
| B01AB04 079 | DS | dalteparinNB102 | 2.5 T i.j. | 6,98 | 7,33 | P | Pfizer Croatia d.o.o. | Pfizer | Fragmin | boč. stakl. 1x100.000 i.j./4 ml | 279.23 | 293,19 | 279.23 | 293,19 |  |
| B05AA05 003 | DS | dekstran 70 |  |  |  | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Soludeks 70 | otop. za inf., boca stakl. 10x500 ml (60 mg/ml) | 33.67 | 35,35 | 336.70 | 353,54 |  |
| B05BB01 030 | PR | natrij-klorid |  |  |  | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Natrii chloridi infundibile | otop. za inf., boca stakl. 10x250 ml (9 mg/ml) | 6.60 | 6,93 | 66.00 | 69,30 |  |
| B05BB02 023 | DS | glukoza + natrij-klorid |  |  |  | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Glukosalina I | otop. za inf., boč. stakl. 20x100 ml (50 mg/ml+9 mg/ml) | 7.70 | 8,09 | 154.00 | 161,70 |  |
| C07AB03 102 |  | atenolol | 75 mg | 0,65 |  | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Atenolol | tbl. 14x100 mg | 0.86 | 0,91 | 12.08 | 12,68 | R |
| D08AX08 961 | DS | etanol + bifenilol |  |  |  | L | Oktal Pharma d.o.o. | Schulke | Desderman N | boca 1x1000 ml (96%+0,1%) | 43.90 | 46,10 | 43.90 | 46,10 |  |
| D08AX08 962 | DS | etanol + bifenilol |  |  |  | L | Oktal Pharma d.o.o. | Schulke | Desderman N | kanister 1x5000 ml (96%+0,1%) | 152.95 | 160,60 | 152.95 | 160,60 |  |
| G04CB01 165 |  | finasterid | 5 mg | 1,31 | 1,37 | O | STADA d.o.o. | Hemofarm AD | Fonsalis | tbl. film obl. 30x5 mg | 1.31 | 1,37 | 39.20 | 41,16 | RSRG06 |
| J01MA14 171 |  | moksifloksacin | 0,4 g | 4,77 | 5,01 | O | DOUBLE-E-PHARMA Limited | Laboratories BTT | Moksifloksacin DOUBLE-E PHARMA | tbl. film obl. 5x400 mg | 4.77 | 5,01 | 23.85 | 25,04 | RSpj05 |
| J01MA14 172 |  | moksifloksacin | 0,4 g | 4,86 | 5,10 | O | DOUBLE-E-PHARMA Limited | Laboratories BTT | Moksifloksacin DOUBLE-E PHARMA | tbl. film obl. 7x400 mg | 4.86 | 5,10 | 34.02 | 35,72 | RSpj05 |
| J01XA01 001 | DS | vankomicinNJ101 | 2 g | 112,28 | 117,89 | P | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o | Adimicin | praš. za otop. za inf., boč. stakl. 1x500 mg | 28.07 | 29,47 | 28.07 | 29,47 |  |
| J01XA01 002 | DS | vankomicinNJ101 | 2 g | 104,22 | 109,43 | P | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o | Adimicin | praš. za otop. za inf., boč. stakl. 1x1000 mg | 52.11 | 54,72 | 52.11 | 54,72 |  |
| L01XE04 161 | DS | sunitinibNL117 |  |  |  | O | Pfizer Ltd. | Pfizer | Sutent | caps. tvrda 30x12,5 mg | 312.60 | 328,23 | 9.378.01 | 9.846,91 |  |
| L01XE04 162 | DS | sunitinibNL117 |  |  |  | O | Pfizer Ltd. | Pfizer | Sutent | caps. tvrda 30x25 mg | 625.20 | 656,46 | 18.756.01 | 19.693,81 |  |
| L01XE04 163 | DS | sunitinibNL117 |  |  |  | O | Pfizer Ltd. | Pfizer | Sutent | caps. tvrda 30x50 mg | 1.250.40 | 1.312,92 | 37.512.02 | 39.387,62 |  |
| L01XE13 164 | DS | afatinibNL419 |  |  |  | O | Boehringer Ingelheim International GmbH | Boehringer Ingelheim | Giotrif | tbl. film obl. 28x50 mg | 493.46 | 518,13 | 13.816.79 | 14.507,63 |  |
| L01XX19 075 | DS | irinotekanNL125 |  |  |  | P | Würth d.o.o. | Ebewe Pharma | Irinotecan Ebewe | konc. za otop. za inf., boč. 1x40 mg/2 ml | 215.10 | 225,86 | 215.10 | 225,86 |  |
| L01XX19 076 | DS | irinotekanNL125 |  |  |  | P | Würth d.o.o. | Ebewe Pharma | Irinotecan Ebewe | konc. za otop. za inf, boč. 1x100 mg/5 ml | 486.00 | 510,30 | 486.00 | 510,30 |  |
| L01XX19 077 | DS | irinotekanNL125 |  |  |  | P | Würth d.o.o. | Ebewe Pharma | Irinotecan Ebewe | konc. za otop. za inf, boč. 1x300 mg/15 ml | 1.458.00 | 1.530,90 | 1.458.00 | 1.530,90 |  |
| L01XX19 078 | DS | irinotekanNL125 |  |  |  | P | Würth d.o.o. | Ebewe Pharma | Irinotecan Ebewe | konc. za otop. za inf, boč. 1x500 mg/25 ml | 2.430.00 | 2.551,50 | 2.430.00 | 2.551,50 |  |
| L02BB03 181 |  | bikalutamid | 50 mg | 6,35 | 6,67 | O | Fresenius Kabi d.o.o. | Fresenius Kabi Oncology Plc. | Bicalutamide Kabi | tbl. film obl. 30x50 mg | 6.35 | 6,67 | 190.44 | 199,96 | RSRL23 |
| L04AA06 165 |  | mikofenolat mofetilNL404 | 2 g | 32,00 | 33,60 | O | STADA d.o.o. | STADA | Mikofenolat STADA | caps. tvrda 100x250 mg | 4.00 | 4,20 | 399.95 | 419,95 | RSRL41 |
| M01AE03 011 | PR | ketoprofen | 0,15 g | 3,93 | 4,13 | P | Belupo d.d. | Belupo | Knavon | amp. 10x100 mg/2ml | 2.62 | 2,75 | 26.23 | 27,54 |  |
| N02AX52 146 |  | tramadol + paracetamol |  |  |  | O | PharmaS d.o.o. | PharmaS d.o.o. | Tramadol/Paracetamol PharmaS | tbl. film obl. 10x(37,5 mg +325 mg) | 0.49 | 0,51 | 4.90 | 5,15 | R |
| N03AX09 101 |  | lamotrigin | 0,3 g | 6,84 | 7,18 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Danoptin | tbl. 30x25 mg | 0.57 | 0,60 | 17.10 | 17,96 | RSRN04 |
| N03AX09 102 |  | lamotrigin | 0,3 g | 9,00 | 9,45 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Danoptin | tbl. 30x50 mg | 1.50 | 1,58 | 45.00 | 47,25 | RSRN04 |
| N03AX09 103 |  | lamotrigin | 0,3 g | 6,72 | 7,06 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Danoptin | tbl. 30x100 mg | 2.24 | 2,35 | 67.20 | 70,56 | RSRN04 |
| S01EA05 776 |  | brimonidin |  |  |  | L | PharmaS d.o.o. | PharmaS d.o.o. | Brimonidin PharmaS | kapi za oči, otop. 1x5 ml (2 mg/ml) | 33.71 | 35,40 | 33.71 | 35,40 | RSRS01 |
| S01EC03 701 |  | dorzolamid | 0,3 ml | 2,42 | 2,54 | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Ulom | kapi za oči 1x5 ml (20 mg/ml) | 40.27 | 42,28 | 40.27 | 42,28 | RSRS01 |
| S01ED01 741 |  | timolol |  |  |  | L | PharmaS d.o.o. | PharmaS d.o.o. | TimoPhar | kapi za oči 1x5 ml (5 mg/ml) | 14.31 | 15,03 | 14.31 | 15,03 | R |
| S01ED51 701 |  | timolol + dorzolamid |  |  |  | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Ulom Plus | kapi za oči, 1x5 ml (5 mg+20 mg/ml) | 40.27 | 42,28 | 40.27 | 42,28 | RSRS01 |
| S01EE01 741 |  | latanoprost |  |  |  | L | PharmaS d.o.o. | PharmaS d.o.o. | LaPhar | kapi za oči 1x2,5 ml (50 mcg/ml) | 40.27 | 42,28 | 40.27 | 42,28 | RSRS01 |

«.

Smjernica pod oznakom »RG07« mijenja se i glasi:

»RG07: Druga linija liječenja sindroma prekomjerno aktivnog mokraćnog mjehura (PAMM) samo u bolesnika u kojih su antimuskarinski lijekovi kontraindicirani ili klinički neučinkoviti nakon 3 mjeseca primjene, po preporuci specijalista urologa ili ginekologa.«.

Članak 2.

Ova Odluka stupa na snagu petnaestoga dana od dana objave u »Narodnim novinama«.

Klasa: 025-04/16-01/171

Urbroj: 338-01-01-16-01

Zagreb, 6. listopada 2016.

Predsjednik
Upravnog vijeća Hrvatskog zavoda
za zdravstveno osiguranje
prim. Milivoj Novak, dr. med., v. r.

90 07.10.2016 Odluka o izmjenama i dopunama Odluke o utvrđivanju Osnovne liste lijekova Hrvatskog zavoda za zdravstveno osiguranje

90 07.10.2016 Odluka o izmjenama i dopunama Odluke o utvrđivanju Osnovne liste lijekova Hrvatskog zavoda za zdravstveno osiguranje

90 07.10.2016 Odluka o izmjenama i dopunama Odluke o utvrđivanju Osnovne liste lijekova Hrvatskog zavoda za zdravstveno osiguranje